Prefrontal cortex 5-HT2 receptors in depression: An [18F]setoperone PET imaging study

American Journal of Psychiatry

Volumn 156, Issue 7, 1999, Pages 1029-1034

  Meyer, Jeffrey H ^a   Kapur, Shitij ^b   Houle, Sylvain ^b   DaSilva, Jean ^b   Owczarek, Beata ^b   Brown, Gregory M ^b   Wilson, Alan A ^b   Kennedy, Sidney H ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN; SEROTONIN 2 RECEPTOR; SEROTONIN RECEPTOR; SETOPERONE;

ADULT; AGE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; FEMALE; HUMAN; MALE; MANIC DEPRESSIVE PSYCHOSIS; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; PRIORITY JOURNAL; SUICIDE ATTEMPT;

ADOLESCENT; ADULT; AGE FACTORS; DEPRESSIVE DISORDER; FEMALE; FLUORINE RADIOISOTOPES; HUMANS; MALE; MIDDLE AGED; PREFRONTAL CORTEX; PYRIMIDINONES; RECEPTORS, SEROTONIN; RESEARCH DESIGN; SUICIDE, ATTEMPTED; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0032968668     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Agren H, Reibring L: PET studies of presynaptic monoamine metabolism in depressed patients and healthy volunteers. Pharmacopsychiatry 1994; 27:2-6
2. Asberg M, Traskman L, Thoren P: 5-HIAA in the cerebrospinal fluid: a biochemical suicide predictor? Arch Gen Psychiatry 1976; 33:1193-1197
3. Heninger GR, Charney DS, Sternberg DE: Serotonergic function in depression. Arch Gen Psychiatry 1984; 41:398-402
4. Siever LJ, Murphy DL, Slater S, de la Vega E, Lipper S: Plasma prolactin changes following fenfluramine in depressed patients compared to controls: an evaluation of central serotonergic responsivity in depression. Life Sci 1984; 34:1029-1039
5. Delgado PL, Charney DS, Price LH, Aghajanian GK, Landis H, Heninger GR: Serotonin function and the mechanism of antidepressant action: reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. Arch Gen Psychiatry 1990; 47:411-418
6. 2 sites in cortex and amygdala. Brain Res 1993; 614:37-44
7. 2 receptor changes in major depression. Biol Psychiatry 1990; 27:489-496
8. 2 receptor binding sites in depressed suicide victims. Brain Res 1988; 443:272-280
9. 2 receptor binding on blood platelets - a peripheral marker for depression? Life Sci 1987; 41:2485-2492
10. Pandey GN, Pandey SC, Janicak PG, Marks RC, Davis JM: Platelet serotonin-2 receptor binding sites in depression and suicide. Biol Psychiatry 1990; 28:215-222
11. 3H]LSD) in the blood platelets of depressed patients. Life Sci 1989; 44:725-734
12. Mikuni M, Kusumi I, Kagaya A, Kuroda Y, Mori H, Takahashi K: Increased 5-HT2 receptor function as measured by serotonin-stimulated phosphoinositide hydrolysis in platelets of depressed patients. Prog Neuropsychopharmacol Biol Psychiatry 1991; 15:49-61
13. Hrdina PD, Bakish D, Chudzik J, Ravindran A, Lapierre YD: Serotonergic markers in platelets of patients with major depression: upregulation of 5-HT2 receptors. J Psychiatry Neurosci 1995; 20:11-19
14. Cowen PJ, Charig EM, Fraser S, Elliott JM: Platelet 5-HT receptor binding during depressive illness and tricyclic antidepressant treatment. J Affect Disord 1987; 13:45-50
15. McBride PA, Brown RP, DeMeo M, Keilp J, Mieczkowski T, Mann JJ: The relationship of platelet 5-HT2 receptor indices to major depressive disorder, personality traits and suicidal behavior. Biol Psychiatry 1994; 35:295-308
16. Bakish D, Cavazzoni P, Chudzik J, Ravindran A, Hrdina PD: Effects of selective serotonin reuptake inhibitors on platelet serotonin parameters in major depressive disorder. Biol Psychiatry 1997; 41:184-190
17. Biegon A, Grinspoon A, Blumenfeld B, Bleich A, Apter A, Mester R: Increased serotonin 5-HT2 receptor binding on blood platelets of suicidal men. Psychopharmacology (Berl) 1990; 100:165-167
18. Pandey GN, Pandey SC, Dwivedi Y, Sharma RP, Janicak PG, Davis JM: Platelet serotonin-2A receptors: a potential biological marker for suicidal behavior. Am J Psychiatry 1995; 6: 850-855
19. Stanley M, Mann JJ: Increased serotonin-2 binding sites in frontal cortex of suicide victims. Lancet 1983; 1:214-216
20. Mann JJ, Stanley M, McBride PA, McEwen BS: Increased serotonin2 and beta-adrenergic receptor binding in the frontal cortices of suicide victims. Arch Gen Psychiatry 1986; 43: 954-959
21. 2 and β-adrenergic receptor binding sites in the brain of suicide victims. Arch Gen Psychiatry 1990; 47:1038-1047
22. McKeith IG, Marshall EF, Ferrier IN, Armstrong MM, Kennedy WN, Perry RH, Perry EK, Eccleston D: 5-HT receptor binding in post-mortem brain from patients with affective disorder. J Affect Disord 1987; 13:67-74
23. Peroutka SJ, Snyder SH: Long-term antidepressant treatment decreases spiroperidol-labeled serotonin receptor binding. Science 1980; 210:88-90
24. 3H) spiroperidol by chronic treatment with the antidepressant amitriptyline. J Pharmacol Exp Ther 1980; 215:582-587
25. Dumbrille-Ross A, Tang SW: Manipulations of synaptic serotonin: discrepancy of effects on serotonin S1 and S2 sites. Life Sci 1983; 32:2677-2684
26. Hrdina PD, Vu TB: Chronic fluoxetine treatment upregulates 5-HT uptake sites and 5-HT2 receptors in rat brain: an autoradiographic study. Synapse 1993; 14:324-331
27. Mann JJ, Underwood MD, Arango V: Postmortem studies of suicide victims, in Biology of Schizophrenia and Affective Disease. Edited by Watson SJ. Washington, DC, American Psychiatric Press, 1996, pp 197-221
28. 2 receptors in depression. Psychiatry Res Neuroimaging 1992; 45:227-237
29. 2 receptor imaging in major depression: focal changes in orbito-insular cortex. Br J Psychiatry 1997; 171:444-448
30. Seeman P: Receptor Tables, vol 2: Drug Dissociation Constants for Neuroreceptors and Transporters. Toronto, SZ Research, 1993
31. De Keyser J, Clayes A, De Backer J-P, Ebinger G, Roels F, Vauquelin G: Autoradiographic localization of D1 and D2 dopamine receptors in the human brain. Neurosci Lett 1988; 91:142-147
32. 18F]setoperone: a new high-affinity ligand for positron emission tomography study of the serotonin-2 receptors in baboon brain in vivo. Eur J Pharmacol 1988; 147:73-82
33. 18F-labeled setoperone. J Neurochem 1990; 54:1744-1754
34. Petit-Taboue M-C, Landau B, Osmont A, Tillet I, Barre L, Baron J-C: Estimation of neocortical serotonin-2 binding potential by single dose fluorine-18-setoperone kinetic PET data analysis. J Nucl Med 1996; 37:95-104
35. 18F-setoperone studied in humans using positron emission tomography. J Neurochem 1992; 58:2303-2310
36. Schotte A, Maloteaux JM, Laduron PM: Characterization and regional distribution of serotonin S2-receptors in human brain. Brain Res 1983; 276:231-235
37. 18F]setoperone in humans. Nucl Med Comm 1997; 18: 395-399
38. 18F]setoperone. Brain 1993:497-510
39. Lewis R, Kapur S, Jones C, DaSilva J, Roy P, Brown G, Wilson A, Houle S, Zipursky R: PET Study of 5-HT2 receptor density in schizophrenia (abstract). Biol Psychiatry 1997; 41(suppl): 63S
40. Spitzer RL, Williams JBW, Gibbon M, First MB: Structured Clinical Interview for DSM-III-R - Non-Patient Edition (SCID-NP, Version 1.0). Washington, DC, American Psychiatric Press, 1990
41. First MB, Spitzer RL, Williams JBW, Gibbon M: Structured Clinical Interview for DSM-IV - Patient Edition (SCID-P). Washington, DC, American Psychiatric Press, 1995
42. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:56-62
43. Crouzel C, Guillaume M, Barre L, Lemaire C, Pike VW: Ligands and tracers for PET studies of the 5-HT system - current status. Int J Rad Appl Instrum B 1992; 19:857-870
44. 2 receptors: implications for the treatment of schizophrenia. Am J Psychiatry 1997; 154:1525-1529
45. Friston KJ, Ashburner J, Frith CD, Poline J-P, Heather JD, Frackowiak RSJ: Spatial registration and normalization of images. Hum Brain Mapp 1995; 2:165-189
46. Friston KJ, Holmes AP, Worsley KJ, Poline J-P, Frith CD, Frackowiak RSJ: Statistical parametric maps in functional imaging: a general linear approach. Hum Brain Mapp 1995; 2: 189-210
47. Friston KJ, Frith CD, Liddle PF, Frackowiak RS: Plastic transformation of PET images. J Comput Assist Tomogr 1991; 15: 634-639
48. 2 receptor mediated wet-dog shake behaviours. Psychopharmacology (Berl) 1992; 108:27-32
49. B receptors in midbrain raphe nuclei and forebrain of rats. Br J Pharmacol 1996; 119:1375-1384
50. 2 serotonin receptors after stroke: lateralized changes and relationship to depression. Am J Psychiatry 1988; 145:937-943
51. Rosner B: Fundamentals of Biostatistics. Toronto, Duxbury Press, 1995, pp 283-285
52. Massou JM, Trichard C, Attar-Levy D, Feline A, Corruble E, Beaufils B, Martinot JL: Frontal 5-HT2A receptors in depressive patients during chronic treatment by selective serotonin reuptake inhibitors. Psychopharmacology (Berl) 1997; 133: 99-101
53. Richelson E: Antidepressants and brain neurochemistry. Mayo Clin Proc 1990; 65:1227-1236
54. Duman RS, Henninger GR, Nestler EJ: A molecular and cellular theory of depression. Arch Gen Psychiatry 1997; 54: 597-608